Danaher Corporation (NYSE:DHR) insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the transaction, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Shares of Danaher Corporation (DHR) opened at 79.82 on Friday. The stock’s 50 day moving average is $82.89 and its 200 day moving average is $84.21. The firm has a market capitalization of $55.45 billion, a price-to-earnings ratio of 25.48 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period last year, the firm earned $0.90 earnings per share. Danaher Corporation’s revenue for the quarter was up 6.3% compared to the same quarter last year. Equities research analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This news story was posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://transcriptdaily.com/2017/08/13/william-king-sells-7458-shares-of-danaher-corporation-dhr-stock-updated-updated.html.
Several research analysts recently commented on the stock. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Wells Fargo & Company assumed coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 target price on the stock. Zacks Investment Research downgraded shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, BTIG Research reiterated a “buy” rating and issued a $92.00 target price on shares of Danaher Corporation in a report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Danaher Corporation currently has a consensus rating of “Buy” and a consensus price target of $91.76.
Institutional investors have recently added to or reduced their stakes in the company. GQG Partners LLC acquired a new position in Danaher Corporation during the second quarter worth approximately $101,000. Peddock Capital Advisors LLC raised its position in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares in the last quarter. Proficio Capital Partners LLC increased its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after buying an additional 598 shares during the last quarter. Acrospire Investment Management LLC increased its stake in shares of Danaher Corporation by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after buying an additional 1,100 shares during the last quarter. Finally, ClariVest Asset Management LLC purchased a new stake in shares of Danaher Corporation during the first quarter worth about $157,000. 76.56% of the stock is currently owned by institutional investors and hedge funds.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.